tiprankstipranks
Trending News
More News >
Pathfinder Cell Therapy (PFND)
:PFND
US Market

Pathfinder Cell Therapy (PFND) Income Statement

Compare
1 Followers

Pathfinder Cell Therapy Income Statement

Last quarter (Q0 0), Pathfinder Cell Therapy's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Pathfinder Cell Therapy's net income was $-289.00K. See Pathfinder Cell Therapy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 14Dec 13Dec 12Dec 11Dec 10
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 0.00$ 17.00K$ 64.00K$ 47.00K$ 0.00
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -1.12M$ -1.59M$ -2.04M$ -3.60M$ -815.00K
Operating Income
$ -1.12M$ -1.60M$ -2.06M$ -3.62M$ -827.00K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -1.39M$ -1.71M$ -2.16M$ -11.27M$ -1.29M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Pathfinder Cell Therapy Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis